Interojo Co

Interojo Co Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Interojo Co (119610.KQ) as of Nov 19, 2026 is 193.56. In the previous year, Cash Conversion Cycle (CCC) was 365.37 — a change of -47.02% (lower).

Cash Conversion Cycle

193.56

YoY

-47.02%

Last updated:

Cash Conversion Cycle (CCC) of Interojo Co is 2025 193.56 . Cash Conversion Cycle (CCC) of Interojo Co was 2024 365.37 . It decreases by -47.02% lower compared to the previous year.

The Interojo Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
400.87 KRW
Jan 1, 2019
393.85 KRW
Jan 1, 2020
431.33 KRW
Jan 1, 2021
361.16 KRW
Jan 1, 2022
377.21 KRW
Jan 1, 2023
404.10 KRW
Jan 1, 2024
365.37 KRW
Jan 1, 2025
193.56 KRW
The Interojo Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
193.56-47.02%
365.37-9.58%
404.10+7.13%
377.21+4.44%
361.16-16.27%
431.33+9.52%
393.85-1.75%
400.87+15.32%
347.62+15.74%
300.36+2.35%
293.47-12.69%
336.14—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Cash Conversion Cycle (CCC) of Interojo Co is 193.56 in 2025.

Cash Conversion Cycle (CCC) of Interojo Co changed from 365.37 to 193.56, representing a -47.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Interojo Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Interojo Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Interojo Co

All Key Metrics — Interojo Co